Last update:

Overweight & Obesity news

Overweight & Obesity

Tirzepatide's benefits fade for most: Weight and health markers rebound after withdrawal, study finds

Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide patients. People with obesity ...

Overweight & Obesity

Metabolites produced in intestine play central role in controlling obesity and diabetes, study shows

A study conducted at Harvard University identified a group of metabolites that travel from the intestine to the liver and then to the heart, where they are pumped throughout the body. These metabolites play an important role ...

Health

Study links America's favorite cooking oil to obesity

Soybean oil, the most widely consumed cooking oil in the United States and a staple of processed foods, contributes to obesity, at least in mice, through a mechanism scientists are now beginning to understand.

Overweight & Obesity

Everyday routines in early infancy may shape later obesity risk

In the United States, approximately 14.7 million children and adolescents between the ages of 2 and 19 are living with obesity, according to the Centers for Disease Control and Prevention. Since children living with obesity ...

Medications

Molecule: What's in this dangerous, illegal slimming pill?

It's the kind of promise that stops thumbs mid-scroll: "Take Molecule and forget food exists." Viral TikTok clips show influencers flaunting rapid weight-loss transformations, tapping into the body image concerns that leave ...

Overweight & Obesity

Gut bacterium could be key to tackling obesity crisis

The internet, libraries and bookshops are full of plans and advice on how to lose weight, from fad diets to intense exercise routines. But there could be another route to keeping the pounds away, and that's with a gut bacterium ...

Health

Midlife weight loss linked to longer, healthier lives

Losing weight via lifestyle adjustments can deliver significant long-term health benefits, without the need for surgery or anti-obesity drugs. Alongside preventing diabetes, it can help ward off chronic conditions including ...

Health

The role of GLP-1 receptor agonists in the management of obesity

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic ...

Neuroscience

Weight loss linked to nerve cells in the brain

Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes, ...